Quaaludes Are Reportedly Making a Comeback, and the Iron Law of Prohibition Explains Why

Methaqualone, the sedative the world knew as Quaaludes, was everywhere in the 1970s and basically nowhere by the end of the 1980s. Congress placed it in Schedule I in 1984, despite FDA and DEA officials acknowledging it had legitimate medical uses, and the last American manufacturer stopped production. For decades, it was a pop-culture punchline more than a real presence on the market.

That’s starting to shift. Researchers detected 2-methoxyqualone, an analog of methaqualone, in illicit drug samples in Pennsylvania and California in April 2026, and some newer analogs are reportedly around 100 times more potent than the original. There’s also a documented case from Australia where a pill sold as a Quaalude actually contained methylmethaqualone. Same name on the label, entirely different chemical inside.

This is what policy folks call the iron law of prohibition: when you crack down on a substance, illicit suppliers move toward more potent, easier-to-conceal alternatives. The original drug had decades of research behind it. Its replacements have mystery toxicity profiles and no quality control. So is this a comeback story, or a cautionary tale wearing a vintage jacket? Drop your take in the comments.